Viz.ai
AI that activates care in seconds
San Francisco, CA, US
Viz.ai is a healthcare AI platform that integrates over 50 FDA-cleared AI algorithms to improve clinical workflows and care coordination. It provides solutions for various conditions like stroke, pulmonary embolism, and intracranial hemorrhage, enabling faster diagnosis and treatment. The platform is deployed in nearly 2,000 hospitals across the United States and Europe, serving over 70,000 healthcare provider users.
How We Help
Problem Statement
Clinicians face challenges in efficiently diagnosing and treating conditions like stroke, pulmonary embolism, and intracranial hemorrhage, leading to delays in care coordination and treatment.
Core Technology
AI algorithms, machine learning, clinical decision support, medical imaging analysis
Key Differentiators
Over 50 FDA-cleared AI algorithms; First company awarded CMS reimbursement for AI (stroke module); Extensive peer-reviewed publications (120+); Rapid scan-to-alert delivery (36 seconds); High clinician engagement (90% click-through rate)
Clinical Focus
Emergency Medicine; Neurology; Cardiology; Pulmonology; Oncology; Radiology
Company Info
- Business Model
- B2B SaaS
- Founded
- 2016
- Total Funding
- 252,000,000
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
50+ FDA 510(k) clearances; first De Novo approval for hypertrophic cardiomyopathy detection; peer-reviewed studies demonstrating 31-minute reduction in door-to-treatment time and improved reperfusion rates
MedStartr Index Score
?What do you think of Viz.ai?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.